Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy Using Cisplatin, Mitomycin, and Adriamycin in Peritoneal Surface Malignancies Also Known as Hyperthermic Intraperitoneal Chemotherapy.

NCT02349958 is registered in ClinicalTrials.gov with Bay Area Gynecology Oncology as lead sponsor.

NCT NCT02349958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02349958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy Using Cisplatin, Mitomycin, and Adriamycin in Peritoneal Surface Malignancies Also Known as Hyperthermic Intraperitoneal Chemotherapy.
Lead sponsor
Bay Area Gynecology Oncology
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2006
Completion date
January 31, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, fallopian tube cancer, gastrointestinal cancers, mesotheliomas, ovarian cancer, peritoneal cancer, uterine cancer